cjc 1295 ipamorelin oral troche CJC-1295 (NO DAC) + – Research Peptide CJC-1295, Ipamorelin, Tesamorelin & Sermorelin:

10.1084/jem.20050915 J

Their ability to target multiple pathwaysfrom initiating apoptosis and detoxifying carcinogens to reprogramming epigenetics and the tumor microenvironmentpositions ITCs as attractive candidates for integrative oncology approaches (113)

Bromelain may increase the cytotoxicity of cisplatin in the treatment of breast cancer as reported in 2 studies with MDA-MB-231 and 4T1 Breast Tumor cell lines ( Bromelain and N-acetylcysteine (NAC) constitute two active ingredients capable of inhibiting the growth and proliferation of induced peritoneal tumors in mice as model animals

Gonzalez-Estrella J

Figure 2 6 Summary The decrease in oocyte quality in EMS patients will make pregnancy hard for women